KVUE | tickerfilter.com

Fundamental analysis

77%

Profitability 89%

Dept financing 45%

Liquidity 42%

Performance 82%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-2.26%

1 Month

0.57%

3 Months

-7.86%

6 Months

16.71%

1 Year

3.66%

2 Year

-21.08%

Key data

Stock price

$21.23

P/E Ratio

41.87

DAY RANGE

$21.05 - $21.28

EPS

$0.38

52 WEEK RANGE

$17.67 - $24.46

52 WEEK CHANGE

$3.06

MARKET CAP

44.547 B

YIELD

3.46%

SHARES OUTSTANDING

1.915 B

DIVIDEND

$0.205

EX-DIVIDEND DATE

08/14/2024

NEXT EARNINGS DATE

N/A

BETA

-0.15

PUBLIC FLOAT

AVERAGE 10 VOLUME

$13,212,180

AVERAGE 30 VOLUME

$12,139,695

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Toilet Preparation Manufacturing
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc.